Transforming Cancer Screening and Diagnosis
Saving and Improving Lives
Innovative liquid biopsy for early detection and diagnosis of cancer
when it matters most
(Cancer Associated Macrophage-Like Cells)
Has my cancer been completely treated?
Residual disease
Early recurrence detection
Sequential monitoring
CAMLs
25-300 µm in size
Present in cancers of all stages
Detected in more than 30 types of cancer
Pan Cancer Screening
Cancer aggressiveness assessment
High-quality tumor DNA for sequencing
What’s the Status of My Cancer?
Is my treatment working?
Assay applicable to all cancers
Enhance patient selection
Provide prognosis at any time
Provide information on treatment response
Provide companion diagnostics - not requiring tissue
Validate drug targets
Deliver high quality DNA for sequencing
Streamline Drug Development and Clinical Trials
CTCs
(Circulating Tumor Cells)
8-25 µm in size
Present in late stage cancers
Detected in breast, prostate, colorectal, and small cell lung cancers
Early determination of response to therapy
Companion diagnostics
Companion diagnostics for mmunotherapy
